Literature DB >> 31022694

CD160 Stimulates CD8+ T Cell Responses and Is Required for Optimal Protective Immunity to Listeria monocytogenes.

Catherine L Tan1,2, Michael J Peluso1,2, Jefte M Drijvers1,2, Camila M Mera1,2, Shannon M Grande1, Keturah E Brown1, Jernej Godec1,2, Gordon J Freeman3, Arlene H Sharpe4,2.   

Abstract

CD160 promotes NK cell cytotoxicity and IFN-γ production, but the function of CD160 on CD8+ T cells remains unclear with some studies supporting a coinhibitory role and others a costimulatory role. In this study, we demonstrate that CD160 has a costimulatory role in promoting CD8+ T cell effector functions needed for optimal clearance of oral Listeria monocytogenes infection. CD160-/- mice did not clear oral L. monocytogenes as efficiently as wild type (WT) littermates. WT RAG-/- and CD160-/- RAG-/- mice similarly cleared L. monocytogenes, indicating that CD160 on NK cells does not contribute to impaired L. monocytogenes clearance. Defective L. monocytogenes clearance is due to compromised intraepithelial lymphocytes and CD8+ T cell functions. There was a reduction in the frequencies of granzyme B-expressing intraepithelial lymphocytes in L. monocytogenes-infected CD160-/- mice as compared with WT littermate controls. Similarly, the frequencies of granzyme B-expressing splenic CD8+ T cells and IFN-γ and TNF-α double-producer CD8+ T cells were significantly reduced in L. monocytogenes-infected CD160-/- mice compared with WT littermates. Adoptive transfer studies showed that RAG-/- recipients receiving CD160-/- CD8+ T cells had a higher mortality, exhibited more weight loss, and had a higher bacterial burden compared with RAG-/- recipients receiving WT CD8+ T cells. These findings demonstrate that CD160 provides costimulatory signals to CD8+ T cells needed for optimal CD8+ T cell responses and protective immunity during an acute mucosal bacterial infection.
Copyright © 2018 The Authors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 31022694     DOI: 10.4049/immunohorizons.1800039

Source DB:  PubMed          Journal:  Immunohorizons        ISSN: 2573-7732


  8 in total

1.  Epithelial HVEM maintains intraepithelial T cell survival and contributes to host protection.

Authors:  Goo-Young Seo; Daisuke Takahashi; Qingyang Wang; Zbigniew Mikulski; Angeline Chen; Ting-Fang Chou; Paola Marcovecchio; Sara McArdle; Ashu Sethi; Jr-Wen Shui; Masumi Takahashi; Charles D Surh; Hilde Cheroutre; Mitchell Kronenberg
Journal:  Sci Immunol       Date:  2022-07-29

2.  Functional Analysis of Immune Signature Genes in Th1* Memory Cells Links ISOC1 and Pyrimidine Metabolism to IFN-γ and IL-17 Production.

Authors:  Yulia Kushnareva; Ian T Mathews; Alexander Y Andreyev; Gokmen Altay; Cecilia S Lindestam Arlehamn; Vijayanand Pandurangan; Roland Nilsson; Mohit Jain; Alessandro Sette; Bjoern Peters; Sonia Sharma
Journal:  J Immunol       Date:  2021-02-05       Impact factor: 5.422

3.  CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+ T Cells.

Authors:  Linxia Zhang; Anli Zhang; Jun Xu; Chao Qiu; Lingyan Zhu; Chenli Qiu; Weihui Fu; Ying Wang; Lilin Ye; Yang-Xin Fu; Chen Zhao; Xiaoyan Zhang; Jianqing Xu
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

4.  A Cross-Protective Vaccine Against 4b and 1/2b Listeria monocytogenes.

Authors:  Fanzeng Meng; Tengfei Zhu; Hao Yao; Zhiting Ling; Youwei Feng; Guo Li; Jing Li; Xinyu Sun; Jiaqi Chen; Chuang Meng; Xin'an Jiao; Yuelan Yin
Journal:  Front Microbiol       Date:  2020-12-11       Impact factor: 5.640

5.  HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.

Authors:  Weifeng Liu; Ting-Fang Chou; Sarah C Garrett-Thomson; Goo-Young Seo; Elena Fedorov; Udupi A Ramagopal; Jeffrey B Bonanno; Qingyang Wang; Kenneth Kim; Scott J Garforth; Kiyokazu Kakugawa; Hilde Cheroutre; Mitchell Kronenberg; Steven C Almo
Journal:  J Exp Med       Date:  2021-10-28       Impact factor: 14.307

6.  PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma.

Authors:  Rebecca M O' Brien; Jason McGrath; Noel E Donlon; Maria Davern; Ashanty M Melo; Croí E Buckley; Andrew D Sheppard; John V Reynolds; Niamh Lynam-Lennon; Stephen G Maher; Joanne Lysaght
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.379

Review 7.  Mechanisms of activation of innate-like intraepithelial T lymphocytes.

Authors:  Maud Vandereyken; Olivia J James; Mahima Swamy
Journal:  Mucosal Immunol       Date:  2020-05-15       Impact factor: 7.313

8.  Expanded antigen-experienced CD160+CD8+effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia.

Authors:  Najmeh Bozorgmehr; Isobel Okoye; Olaide Oyegbami; Lai Xu; Amelie Fontaine; Nanette Cox-Kennett; Loree M Larratt; Mark Hnatiuk; Andrei Fagarasanu; Joseph Brandwein; Anthea C Peters; Shokrollah Elahi
Journal:  J Immunother Cancer       Date:  2021-04       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.